Literature DB >> 18777590

Role of mucosal dendritic cells in inflammatory bowel disease.

Jan Hendrik Niess1.   

Abstract

The gastrointestinal innate and adaptive immune system continuously faces the challenge of potent stimuli from the commensal microflora and food constituents. These local immune responses require a tight control, the outcome of which is in most cases the induction of tolerance. Local T cell immunity is an important compartment of the specific intestinal immune system. T cell reactivity is programmed during the initial stage of its activation by professional presenting cells. Mucosal dendritic cells (DCs) are assumed to play key roles in regulating immune responses in the antigen-rich gastrointestinal environment. Mucosal DCs are a heterogeneous population that can either initiate (innate and adaptive) immune responses, or control intestinal inflammation and maintain tolerance. Defects in this regulation are supposed to lead to the two major forms of inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC). This review will discuss the emerging role of mucosal DCs in regulating intestinal inflammation and immune responses.

Entities:  

Mesh:

Year:  2008        PMID: 18777590      PMCID: PMC2744003          DOI: 10.3748/wjg.14.5138

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  128 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 2.  Collaboration of epithelial cells with organized mucosal lymphoid tissues.

Authors:  M R Neutra; N J Mantis; J P Kraehenbuhl
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

Review 3.  Man the barrier! Strategic defences in the intestinal mucosa.

Authors:  C Nagler-Anderson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

4.  Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine.

Authors:  Hiromasa Hamada; Takachika Hiroi; Yasuhiro Nishiyama; Hidemi Takahashi; Yohei Masunaga; Satoshi Hachimura; Shuichi Kaminogawa; Hiromi Takahashi-Iwanaga; Toshihiko Iwanaga; Hiroshi Kiyono; Hiroshi Yamamoto; Hiromichi Ishikawa
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis.

Authors:  Y Ikeda; F Akbar; H Matsui; M Onji
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

6.  CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.

Authors:  S E Girardin; R Tournebize; M Mavris; A L Page; X Li; G R Stark; J Bertin; P S DiStefano; M Yaniv; P J Sansonetti; D J Philpott
Journal:  EMBO Rep       Date:  2001-07-19       Impact factor: 8.807

7.  Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model.

Authors:  F Leithäuser; Z Trobonjaca; P Möller; J Reimann
Journal:  Lab Invest       Date:  2001-10       Impact factor: 5.662

8.  Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.

Authors:  P Björck
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells.

Authors:  Mathias W Hornef; Teresa Frisan; Alain Vandewalle; Staffan Normark; Agneta Richter-Dahlfors
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  30 in total

1.  NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells.

Authors:  Holger Schäffler; Dogan Doruk Demircioglu; Daniel Kühner; Sarah Menz; Annika Bender; Ingo B Autenrieth; Peggy Bodammer; Georg Lamprecht; Friedrich Götz; Julia-Stefanie Frick
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Authors:  Sumathi Sankaran-Walters; Kanat Ransibrahmanakul; Irina Grishina; Jason Hung; Enrique Martinez; Thomas Prindiville; Satya Dandekar
Journal:  J Clin Virol       Date:  2010-10-28       Impact factor: 3.168

3.  Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis.

Authors:  Lillian Maggio-Price; Audrey Seamons; Helle Bielefeldt-Ohmann; Weiping Zeng; Thea Brabb; Carol Ware; Mingzu Lei; Robert M Hershberg
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

Review 4.  T-bet-/- RAG2-/- ulcerative colitis: the role of T-bet as a peacekeeper of host-commensal relationships.

Authors:  Wendy S Garrett; Laurie H Glimcher
Journal:  Cytokine       Date:  2009-08-08       Impact factor: 3.861

Review 5.  Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.

Authors:  Laszlo Bene; Andras Falus; Noemi Baffy; Andras Kristof Fulop
Journal:  Pathol Oncol Res       Date:  2011-06-17       Impact factor: 3.201

Review 6.  Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Authors:  Ross John Porter; Caroline Andrews; Daniel Paul Brice; Scott Kenneth Durum; Mairi Hall McLean
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

Review 7.  Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells.

Authors:  Elizabeth R Mann; Xuhang Li
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

8.  Immunopathogenesis of inflammatory bowel disease.

Authors:  Julien Matricon; Nicolas Barnich; Denis Ardid
Journal:  Self Nonself       Date:  2010-10

9.  Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

Authors:  Justin R Henning; Christopher S Graffeo; Adeel Rehman; Nina C Fallon; Constantinos P Zambirinis; Atsuo Ochi; Rocky Barilla; Mohsin Jamal; Michael Deutsch; Stephanie Greco; Melvin Ego-Osuala; Usama Bin-Saeed; Raghavendra S Rao; Sana Badar; Juan P Quesada; Devrim Acehan; George Miller
Journal:  Hepatology       Date:  2013-06-24       Impact factor: 17.425

10.  Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis.

Authors:  K Flück; G Breves; J Fandrey; S Winning
Journal:  Mucosal Immunol       Date:  2015-07-29       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.